Global Natamycin Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Natamycin Market
The global Natamycin market size is projected to reach US$ 269.9 million by 2027, from US$ 174 million in 2020, at a CAGR of 6.4% during 2021-2027.
Global Natamycin Scope and Segment
The global Natamycin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Natamycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Glucose-based
Lactose-based
Sodium chloride-based
By the end users/application, this report covers the following segments
Food
Medical
Others
Competitive Landscape:
The report provides a list of all the key players in the Natamycin market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Natamycin key manufacturers in this market include:
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome

TABLE OF CONTENT

1 Natamycin Market Overview
1.1 Natamycin Product Overview
1.2 Natamycin Market Segment by Type
1.2.1 Glucose-based
1.2.2 Lactose-based
1.2.3 Sodium chloride-based
1.3 Global Natamycin Market Size by Type
1.3.1 Global Natamycin Market Size Overview by Type (2016-2027)
1.3.2 Global Natamycin Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Natamycin Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Natamycin Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Natamycin Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Natamycin Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Natamycin Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Natamycin Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Natamycin Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Natamycin Sales Breakdown by Type (2016-2030)
1.4.2 Europe Natamycin Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Natamycin Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Natamycin Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Natamycin Sales Breakdown by Type (2016-2030)

2 Global Natamycin Market Competition by Company
2.1 Global Top Players by Natamycin Sales (2016-2030)
2.2 Global Top Players by Natamycin Revenue (2016-2030)
2.3 Global Top Players Natamycin Price (2016-2030)
2.4 Global Top Manufacturers Natamycin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Natamycin Market Competitive Situation and Trends
2.5.1 Natamycin Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Natamycin Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natamycin as of 2020)
2.7 Date of Key Manufacturers Enter into Natamycin Market
2.8 Key Manufacturers Natamycin Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Natamycin Status and Outlook by Region
3.1 Global Natamycin Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Natamycin Historic Market Size by Region
3.2.1 Global Natamycin Sales in Volume by Region (2016-2030)
3.2.2 Global Natamycin Sales in Value by Region (2016-2030)
3.2.3 Global Natamycin Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Natamycin Forecasted Market Size by Region
3.3.1 Global Natamycin Sales in Volume by Region (2022-2027)
3.3.2 Global Natamycin Sales in Value by Region (2022-2027)
3.3.3 Global Natamycin Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Natamycin by Application
4.1 Natamycin Market Segment by Application
4.1.1 Food
4.1.2 Medical
4.1.3 Others
4.2 Global Natamycin Market Size by Application
4.2.1 Global Natamycin Market Size Overview by Application (2016-2027)
4.2.2 Global Natamycin Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Natamycin Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Natamycin Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Natamycin Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Natamycin Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Natamycin Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Natamycin Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Natamycin Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Natamycin Sales Breakdown by Application (2016-2030)
4.3.2 Europe Natamycin Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Natamycin Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Natamycin Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Natamycin Sales Breakdown by Application (2016-2030)

5 North America Natamycin by Country
5.1 North America Natamycin Historic Market Size by Country
5.1.1 North America Natamycin Sales in Volume by Country (2016-2030)
5.1.2 North America Natamycin Sales in Value by Country (2016-2030)
5.2 North America Natamycin Forecasted Market Size by Country
5.2.1 North America Natamycin Sales in Volume by Country (2022-2027)
5.2.2 North America Natamycin Sales in Value by Country (2022-2027)

6 Europe Natamycin by Country
6.1 Europe Natamycin Historic Market Size by Country
6.1.1 Europe Natamycin Sales in Volume by Country (2016-2030)
6.1.2 Europe Natamycin Sales in Value by Country (2016-2030)
6.2 Europe Natamycin Forecasted Market Size by Country
6.2.1 Europe Natamycin Sales in Volume by Country (2022-2027)
6.2.2 Europe Natamycin Sales in Value by Country (2022-2027)

7 Asia-Pacific Natamycin by Region
7.1 Asia-Pacific Natamycin Historic Market Size by Region
7.1.1 Asia-Pacific Natamycin Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Natamycin Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Natamycin Forecasted Market Size by Region
7.2.1 Asia-Pacific Natamycin Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Natamycin Sales in Value by Region (2022-2027)

8 Latin America Natamycin by Country
8.1 Latin America Natamycin Historic Market Size by Country
8.1.1 Latin America Natamycin Sales in Volume by Country (2016-2030)
8.1.2 Latin America Natamycin Sales in Value by Country (2016-2030)
8.2 Latin America Natamycin Forecasted Market Size by Country
8.2.1 Latin America Natamycin Sales in Volume by Country (2022-2027)
8.2.2 Latin America Natamycin Sales in Value by Country (2022-2027)

9 Middle East and Africa Natamycin by Country
9.1 Middle East and Africa Natamycin Historic Market Size by Country
9.1.1 Middle East and Africa Natamycin Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Natamycin Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Natamycin Forecasted Market Size by Country
9.2.1 Middle East and Africa Natamycin Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Natamycin Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Natamycin Business
10.1 Danisco
10.1.1 Danisco Corporation Information
10.1.2 Danisco Introduction and Business Overview
10.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Danisco Natamycin Products Offered
10.1.5 Danisco Recent Development
10.2 DSM
10.2.1 DSM Corporation Information
10.2.2 DSM Introduction and Business Overview
10.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.2.4 DSM Natamycin Products Offered
10.2.5 DSM Recent Development
10.3 VGP
10.3.1 VGP Corporation Information
10.3.2 VGP Introduction and Business Overview
10.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.3.4 VGP Natamycin Products Offered
10.3.5 VGP Recent Development
10.4 Handary
10.4.1 Handary Corporation Information
10.4.2 Handary Introduction and Business Overview
10.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.4.4 Handary Natamycin Products Offered
10.4.5 Handary Recent Development
10.5 AMTECH BIOTECH
10.5.1 AMTECH BIOTECH Corporation Information
10.5.2 AMTECH BIOTECH Introduction and Business Overview
10.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.5.4 AMTECH BIOTECH Natamycin Products Offered
10.5.5 AMTECH BIOTECH Recent Development
10.6 Silver-Elephant
10.6.1 Silver-Elephant Corporation Information
10.6.2 Silver-Elephant Introduction and Business Overview
10.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.6.4 Silver-Elephant Natamycin Products Offered
10.6.5 Silver-Elephant Recent Development
10.7 Lanzhou Weiri
10.7.1 Lanzhou Weiri Corporation Information
10.7.2 Lanzhou Weiri Introduction and Business Overview
10.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Lanzhou Weiri Natamycin Products Offered
10.7.5 Lanzhou Weiri Recent Development
10.8 Langfang Meihua
10.8.1 Langfang Meihua Corporation Information
10.8.2 Langfang Meihua Introduction and Business Overview
10.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Langfang Meihua Natamycin Products Offered
10.8.5 Langfang Meihua Recent Development
10.9 Zhengzhou New Frey
10.9.1 Zhengzhou New Frey Corporation Information
10.9.2 Zhengzhou New Frey Introduction and Business Overview
10.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.9.4 Zhengzhou New Frey Natamycin Products Offered
10.9.5 Zhengzhou New Frey Recent Development
10.10 Chihon
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Natamycin Product Category, Application and Specification
10.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Chihon Recent Development
10.11 Jiaozuo Joincare
10.11.1 Jiaozuo Joincare Corporation Information
10.11.2 Jiaozuo Joincare Introduction and Business Overview
10.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Jiaozuo Joincare Natamycin Products Offered
10.11.5 Jiaozuo Joincare Recent Development
10.12 Beijing Oriental Rada
10.12.1 Beijing Oriental Rada Corporation Information
10.12.2 Beijing Oriental Rada Introduction and Business Overview
10.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Beijing Oriental Rada Natamycin Products Offered
10.12.5 Beijing Oriental Rada Recent Development
10.13 Pucheng Lifecome
10.13.1 Pucheng Lifecome Corporation Information
10.13.2 Pucheng Lifecome Introduction and Business Overview
10.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2016-2030)
10.13.4 Pucheng Lifecome Natamycin Products Offered
10.13.5 Pucheng Lifecome Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Natamycin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Natamycin Industrial Chain Analysis
11.4 Natamycin Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Natamycin Distributors
12.3 Natamycin Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample